Answers are grounded in this paper and cite their sources.
Randomized trial investigates gut microbiota and metabolites in adults with obesity, suggesting benefits for cardiometabolic health.
OBJECTIVE: This study aimed to investigate whether the time of the eating window during time-restricted eating (TRE) alters the gut microbiota and metabolomic profiles and to determine their relationship with cardiometabolic risk factors in adults with overweight or obesity. METHODS: In an 8-week randomized controlled trial, 60 young adults with overweight or obesity were randomized to 6-h eTRE (7 a.m.-1 p.m.), 6-h lTRE (12 p.m.-6 p.m.), or a control group (ad libitum). The gut microbiota was analyzed by 16S ribosomal RNA (16S rRNA) sequencing and serum metabolomics were quantified by liquid chromatography-mass spectrometry (LC-MS). RESULTS: After 8 weeks, compared to the control group, the 6-h eTRE increased abundance of Faecalibacterium and Lactobacillus and decreased abundance of unclassified_f_Peptostreptococcaceae, whereas 6-h lTRE significantly increased abundance of Faecalibacterium and decreased abundance of Shigella (all p < 0.05). Differential serum metabolites (e.g., L-malic acid in eTRE; isovaleric acid in lTRE) were significantly associated with changes in weight, body fat, and systolic blood pressure (SBP) (p < 0.05). CONCLUSIONS: Time-restricted eating may be beneficial to weight loss and cardiometabolic health improvement by regulating gut microbiota and serum metabolites. TRIAL REGISTRATION: Chinese Clinical Trial Registry ChiCTR2000039115.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: